Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- SRH Wald-Klinikum Gera GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT03035188
- Locations
- 🇩🇪
HELIOS Klinikum Erfurt, Erfurt, Germany
🇩🇪Klinikum Augsburg Süd, Augsburg, Germany
🇩🇪Charité - Universitätsmedizin Berlin, Berlin, Germany
© Copyright 2024. All Rights Reserved by MedPath